Knowledge Hub

In this Application Note we also look at how Microfluidizer^® Technology plays a vital role in producing high performance energy storage systems.

With extensive experience in both equipment and application, our engineers have helped 100's of customers reach their nanotechnology solutions utilizing Microfluidizer® technology.

Discover more about how Microfluidizer® technology is an ideal alternative cell lysing method for harvesting vectors which are the most commonly used carriers in delivery of therapeutic genes.

Read a collection of peer reviews and case studies for insight into the advantages of choosing Microfluidizer® processors over other methods for cell lysis.

When RNA by itself is not viable as a vaccine, read how the creation and production of a drug delivery system for the next generation of vaccines is required.

Learn more about our case study with Cayman Chemical Company which uses Microfluidizer top-down technology to achieve small, uniform particle sizes for LNP production.

Learn more about an innovative new greener process to produce liposomes without the use of solvents that can be efficiently scaled for production.

With less side-effects than traditional systems, learn how nanoparticle albumin bound (nab) paclitaxel is a critically important method in chemotherapy drug delivery. See how our technology plays a vital role in the process.

Creating a quality nanoemulsion requires selecting the right emulsification method. Learn how Microfluidizer® technology compares to Ultrasonic technology.

When creating a nanoemulsion to be used in beverages, it is important to use a method which achieves increased stability, no loss of active ingredients and is contamination free.

With its rapid onset, short recovery time and minimal side effects, learn how producing an efficient propofol emulsion is important for creating critical sedatives and anesthesia. drugs.

From plasma expanders, carriers for water-insoluble drugs, in drug formulation, as immune stimulators and vaccine antigens, learn more about the diversity of polysaccharide and its role in pharmaceuticals.

Biocompatible and biodegradable polymer nanoparticles represent one of the most innovative delivery systems. Learn about its ability to deliver a combination of different therapeutic ingredients and its importance in pharmaceuticals.

Graphene is ultra-light, extremely tough and incredibly flexible and is a superior barrier and efficient conductor. Learn more about our scalable method to exfoliate graphene.

With seamless scale-up from lab to production, Microfluidizer® technology gets unparalleled results. Learn how Microfluidics achieves consistent results batch-to-batch.

It’s essential that success in the lab can be duplicated into production with consistent results batch-to-batch. Learn how Microfluidizer® technology can be scaled up from lab to pilot to production with repeatable results.

Microfluidics leads the way in solving nanotechnology challenges. From lab-scale to production-scale, Microfluidizer® processors provide optimal performance & superior quality.

Microfluidics offers a full range of aftermarket services to keep your processor in optimal operating condition.

Learn why top cosmetic companies choose Microfluidizer® technology to gain a competitive edge in today’s market for achieving superior creams, lotions and fragrances.

This digitally controlled lab unit is designed for the budget-conscious researcher working with small sample material processing.

Learn more about our digitally controlled, electrically powered lab unit for small sample processing.

Discover our simple to use, premium 'plug and play' benchtop homogenizer for continuous high shear processing in the lab.

The M110P models are designed to reliably achieve continuous operating pressures up to 30,000 psi. The Pharma Basic model is available for clinical batch processing.

Lab Unit for small sample material processing, an excellent choice for academic and commercial customers working with high-value samples to the milliliter scale.

For micro-mixing in the lab, find out more about our portable, high-pressure pneumatic, high shear fluid lab homogenizer that consistently delivers big results.

Versatile and easy-of-use, these sanitary standard & lightweight air-driven homogenizers offer repeatable, premium results at an affordable price.         

An electric-hydraulic pilot scale homogenizer for continuous, high shear fluid processing in small volumes where results can be guaranteed to fully scale up to production volumes.

Discover more about this popular and hardworking electric-hydraulic pilot-scale homogenizer designed to achieve cGMP standards when processing small sample sizes.

Designed to achieve cGMP standards, the M110EH Aseptic model suits Biopharmaceutical requirements and is ideal for pilot scale batch processing.

Bridging the gap between lab and production, this homogenizer is the ideal solution to perform high shear fluid processing working with small sample sizes.

The M815 Biopharma Basic processor is designed to achieve cGMP standards, processing pilot & small production batches, allowing users to replicate operating conditions.

Specifically designed to achieve cGMP standards, this model provides superior results for production environments with guaranteed scale-up from lab and pilot scale volumes.

Utilizing a hybrid approach which incorporates Microfluidics proprietary Interaction Chamber™ technology, with a unique sanitary, electric pumping system, the MP350 Microlyser™ delivers superior cell disruption yields.

Dr. Yang Su addresses the challenges top cosmetic companies must overcome to produce superior products that are free from contaminants and with long shelf-lives.  We address how Microfluidizer® Technology resolves cosmetic application challenges including solvent-free perfume, specialty shampoo, liposomal serum, cell lysis for cosmetic application and process scale-up.

Dr. Darrick Carter discusses HDT Bio's proprietary drug delivery technology and the role Microfluidizer® processors play in addressing an efficient, scalable production solution.

Microfluidics' Manager of New Technology and Application, Dr. Yang Su, provided an overview of manufacturing considerations & benefits of uniform processing of Microfluidizer^® technology and how it can be applied in processing a variety of materials across pharmaceutical, cosmetic, nutraceutical and energy applications.

Dr. Yang Su, of Microfluidics International Corp., presenting: Scalable Microfluidizer® Technology for Pharmaceutical Drug Delivering Nanoparticle Manufacturing at the 2022 International Pharmaceutical Technology Symposium (IPTS).

Presenting how Microfluidizer^® technology, through a solvent-free manufacturing process, can help solve bioavailability issues and is particularly suitable for industrial transposition.

Find out how Microfluidizer® high shear processors are a Scalable Solution for Large Scale Manufacturing of Vaccines.

Learn about drug delivering nanoparticles and Microfluidizer® technology's role in solving production challenges.

Dr. Chris Fox of the Infectious Disease Research Institute discusses their vaccine and adjuvant development programme and production scale-up.

Find out more about Microfluidics technology and the benefits of the Microfluidization process in the production of Squalene-based nanoemulsions.

A webinar discussion on how to solve pharmaceutical nanotechnology application challenges from development to production.

This video provides an overview of cell disruption and how Microfluidizer technology achieves the highest level of product recovery across different cell types.

Watch this video to find out why top businesses choose Microfluidics for their nanoemulsion needs.

Discover what makes Microfluidizer® technology superior and how it differentiates over conventional homogenizers.

This video provides an overview of Vaccines, exploring Antigens, Adjuvants and Delivery Systems.

A case study from Microfluidics covering Vaccine Adjuvant Production - the history, production methods, MF59, Nanoemulsions, Filtering.

Success in the lab is only useful if the product can easily be transferred to small cGMP batches for clinical trials, and ultimately production scale.

Whether producing small batches or millions of doses, Microfluidizer® technology offers repeatable, scalable results for LNP manufacturing. 

Lipid Nanoparticles are game-changing pharmaceutical technology which are revolutionizing vaccine, gene and cancer developments.

Watch our video to learn about Microfluidics Interaction Chamber™, applications and scale-up capabilities.

Learn more about how Microfluidizer® technology provides guaranteed scale-up from the R&D lab to production.

Discover how Microfluidizer® Technology differentiates itself from other high-pressure homogenizers.

Interaction Chambers™ are designed to provide repeatable results and consistent quality, no matter the volume.

Microfluidics is the gold standard in cell disruption due to its high recovery with less waste and damage.

Microfluidics provides high shear technology for stable, consistent results with precise control for nanoemulsion processing.

Microfluidics provides best-in-class processors from lab scale to production scale equipment across numerous applications.

Compared to our competition, Microfluidizer® processors provide greater shear forces, particle size reductions, less energy and fewer passes.

High shear processors for scalable vaccine production achieving best-in-class results in pharmaceutical applications with cGMP requirements.

With fewer side effects than traditional chemotherapy systems, learn more about Microfluidics’ role in creating nab (nanoparticle album bound) drug delivery technology.

Microfluidizer® equipment provides a superior technology for cell disruption by lessening waste, limiting damage and guaranteeing scalability. Watch the video to learn more.

Microfluidics achieves the highest level of product recovery across different cell types. An efficient integrated cooling system ensures that proteins stay intact - even under high pressure processing, keeping protein yields high.

This video shows our full range of benchtop, pilot-scale, and production-scale Microfluidizer® processors which can be linearly scaled to achieve consistent, repeatable results.

Discover novel, solvent-free methods for producing lipid-based nanoparticles (liposomes, lipid nanoparticles and solid lipid nanoparticles).

An In-depth Comparison of Biotest HSA and Recombinant HSA for the Preparation of Nano Albumin Bound (nab) Paclitaxel using Microfluidizer® Technology.